VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,441,180 | -40.0% | 314,991 | -11.3% | 0.00% | – |
| Q2 2023 | $4,065,701 | +46.6% | 355,083 | -1.3% | 0.00% | – |
| Q1 2023 | $2,773,000 | +141163.4% | 359,741 | +11.8% | 0.00% | – |
| Q4 2022 | $1,963 | -99.9% | 321,795 | 0.0% | 0.00% | – |
| Q3 2022 | $1,905,000 | +13.3% | 321,795 | +13.1% | 0.00% | – |
| Q2 2022 | $1,682,000 | -37.0% | 284,558 | -18.7% | 0.00% | – |
| Q1 2022 | $2,669,000 | +91.3% | 350,217 | -32.0% | 0.00% | – |
| Q4 2021 | $1,395,000 | -32.3% | 514,664 | -34.4% | 0.00% | – |
| Q3 2021 | $2,061,000 | -45.7% | 784,003 | -14.8% | 0.00% | – |
| Q2 2021 | $3,799,000 | -40.2% | 919,826 | -31.8% | 0.00% | -100.0% |
| Q1 2021 | $6,353,000 | +45.2% | 1,348,556 | +120.4% | 0.00% | 0.0% |
| Q4 2020 | $4,376,000 | +11.9% | 611,888 | +73.3% | 0.00% | 0.0% |
| Q3 2020 | $3,910,000 | -2.8% | 353,054 | +10.8% | 0.00% | 0.0% |
| Q2 2020 | $4,022,000 | +50.9% | 318,663 | +9.4% | 0.00% | 0.0% |
| Q1 2020 | $2,666,000 | -16.5% | 291,377 | +27.2% | 0.00% | 0.0% |
| Q4 2019 | $3,194,000 | -7.0% | 229,028 | +14.8% | 0.00% | 0.0% |
| Q3 2019 | $3,433,000 | -60.0% | 199,459 | -38.9% | 0.00% | -50.0% |
| Q2 2019 | $8,590,000 | +75.9% | 326,643 | +28.0% | 0.00% | +100.0% |
| Q1 2019 | $4,884,000 | +80.4% | 255,192 | -11.4% | 0.00% | 0.0% |
| Q4 2018 | $2,708,000 | -36.8% | 288,031 | +27.2% | 0.00% | 0.0% |
| Q3 2018 | $4,285,000 | +3.1% | 226,494 | +6.4% | 0.00% | 0.0% |
| Q2 2018 | $4,158,000 | +35.4% | 212,806 | +30.2% | 0.00% | 0.0% |
| Q1 2018 | $3,071,000 | +359.0% | 163,433 | +305.3% | 0.00% | – |
| Q4 2017 | $669,000 | +147.8% | 40,328 | +191.6% | 0.00% | – |
| Q3 2017 | $270,000 | -87.5% | 13,829 | -91.5% | 0.00% | – |
| Q1 2017 | $2,158,000 | -17.5% | 163,000 | -20.6% | 0.00% | -100.0% |
| Q4 2016 | $2,616,000 | +3.1% | 205,357 | -2.8% | 0.00% | 0.0% |
| Q3 2016 | $2,537,000 | -20.0% | 211,200 | -26.8% | 0.00% | 0.0% |
| Q2 2016 | $3,170,000 | +241.6% | 288,425 | +171.3% | 0.00% | – |
| Q1 2016 | $928,000 | -62.8% | 106,300 | -6.6% | 0.00% | -100.0% |
| Q4 2015 | $2,493,000 | – | 113,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |